ACE inhibitors and ARBs: One or the other—not both—for high-risk patients

MOspace/Manakin Repository

Breadcrumbs Navigation

ACE inhibitors and ARBs: One or the other—not both—for high-risk patients

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/5429

[+] show full item record


Title: ACE inhibitors and ARBs: One or the other—not both—for high-risk patients
Author: Misra, Shamita; Stevermer, James J.; Ewigman, Bernard
Keywords: type 2 diabetes
hypertension
albuminuria
renal function
Date: 2009-01
Publisher: Family Physicians Inquiries Network
Citation: Journal of Family Practice, 58(1) 2009: 24+.
Abstract: Avoid prescribing an angiotensin-converting enzyme (ACE) inhibitor and an angiotensin receptor blocker (ARB) for patients at high risk of vascular events or renal dysfunction. The combination does not reduce poor outcomes, and leads to more adverse drug-related events than an ACE inhibitor or ARB alone. Strength of recommendation B: 1 large, high-quality randomized controlled trial (RCT).
URI: http://hdl.handle.net/10355/5429

This item appears in the following Collection(s)

[+] show full item record